Cargando…
A Research Study to Measure the Efficacy of Terminating Cervical Cancer via Customized Optimum Pathway
BACKGROUND: To develop a precise prognostic model of overall survival in patients with terminating cervical cancer based on surveillance, epidemiology, and end results (SEER) program. METHODS: The patients were retrieved from SEER data who are diagnosed with terminating cervical cancer from 2004 to...
Autores principales: | Zhang, Xianyu, Ma, Huan, Lu, Xiurong, Zhang, Zhilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941559/ https://www.ncbi.nlm.nih.gov/pubmed/35340234 http://dx.doi.org/10.1155/2022/7872915 |
Ejemplares similares
-
Retracted: A Research Study to Measure the Efficacy of Terminating Cervical Cancer via Customized Optimum Pathway
por: Healthcare Engineering, Journal of
Publicado: (2023) -
miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway
por: Lu, Xiurong, et al.
Publicado: (2021) -
MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1
por: Lu, Xiurong, et al.
Publicado: (2021) -
MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2
por: Lu, Xiurong, et al.
Publicado: (2021) -
ITGA7, CD133, ALDH1 are inter‐correlated, and linked with poor differentiation, lymph node metastasis as well as worse survival in surgical cervical cancer
por: Yuan, Na, et al.
Publicado: (2022)